11-beta-Hydroxysteroid Dehydrogenase Type 2
Also known as11 beta Hydroxysteroid Dehydrogenase Type 2 · 11 beta-HSD2 · 11 beta-Hydroxysteroid Dehydrogenase Type 2 · 11beta-HSD2 · 11beta-HSD2 Reductase · 11beta-Hydroxysteroid Dehydrogenase Type 2 · 11beta Hydroxysteroid Dehydrogenase Type 2
Definition
An high-affinity, NAD-dependent 11-beta-hydroxysteroid dehydrogenase that acts unidirectionally to catalyze the dehydrogenation of CORTISOL to CORTISONE. It is found predominantly in mineralocorticoid target tissues such as the KIDNEY; COLON; SWEAT GLANDS; and the PLACENTA. Absence of the enzyme leads to a fatal form of childhood hypertension termed, APPARENT MINERALOCORTICOID EXCESS SYNDROME.
MeSH classification
- D08.811.682.047.436.174.600
- D08.811.682.047.820.100.600
Need clinical context, treatments, or patient-language explanation?
Ask GoDavaii AI about 11-beta-Hydroxysteroid Dehydrogenase Type 2Related concepts
11-beta-Hydroxysteroid Dehydrogenase Type 1
A low-affinity 11 beta-hydroxysteroid dehydrogenase found in a variety of tissues, most notably in LIVER; LUNG; ADIPOSE TISSUE; vascular tis…
11-beta-Hydroxysteroid Dehydrogenases
Hydroxysteroid dehydrogenases that catalyzes the reversible conversion of CORTISOL to the inactive metabolite CORTISONE. Enzymes in this cla…
Common questions about 11-beta-Hydroxysteroid Dehydrogenase Type 2
What does 11-beta-Hydroxysteroid Dehydrogenase Type 2 mean in medicine?
Is 11-beta-Hydroxysteroid Dehydrogenase Type 2 known by any other names?
Where does 11-beta-Hydroxysteroid Dehydrogenase Type 2 sit in the medical classification?
Where can I get a plain-language explanation of 11-beta-Hydroxysteroid Dehydrogenase Type 2?
Source: NIH MeSH 2026 (D043209) — National Library of Medicine, public domain. View official MeSH record ↗